fcmedicineФундаментальная и клиническая медицинаFundamental and Clinical Medicine2500-07642542-0941КемГМУ10.23946/2500-0764-2023-8-3-107-115fcmedicine-763Research ArticleОБЗОРНЫЕ СТАТЬИREVIEW ARTICLESБеременность и фиброид (лейомиома) матки. Версии и контраверсииPregnancy and uterine fibroids (leiomyoma): a critical reviewhttps://orcid.org/0000-0001-9673-9077ФаткуллинИ. Ф.FatkullinI. F.

Фаткуллин Ильдар Фаридович - доктор медицинских наук, профессор, заведующий кафедрой акушерства и гинекологии им. проф. В.С. Груздева.

420012, Республика Татарстан, Казань, улица Бутлерова, д. 49

Ildar F. Fatkullin - MD, DSc, Professor, Head of the Department of Obstetrics and Gynecology, Kazan Medical University.

49, Butlerova Street, Kazan, 420012

https://orcid.org/0000-0002-3871-045XОрловЮ. В.OrlovYu. V.

Орлов Юрий Валерьевич - кандидат медицинских наук, руководитель аккредитационно-симуляционного центра, доцент кафедры акушерства и гинекологии им. проф. В.С. Груздева.

420012, Республика Татарстан, Казань, улица Бутлерова, д. 49

Yuriy V. Orlov - MD, PhD, Head of the Accreditation and Simulation Center, Associate Professor, Department of Obstetrics and Gynecology, Kazan Medical University.

49, Butlerova Street, Kazan, 420012

scenter@kazangmu.ruhttps://orcid.org/0000-0003-0361-2785ФаткуллинаЛ. С.FatkullinaL. S.

Фаткуллина Лариса Сергеевна - кандидат медицинских наук, доцент кафедры акушерства и гинекологии им. проф. В.С. Груздева.

420012, Республика Татарстан, Казань, улица Бутлерова, д. 49

Larisa S. Fatkullina - MD, PhD, Associate Professor, Department of Obstetrics and Gynecology, Kazan Medical University.

49, Butlerova Street, Kazan, 420012

https://orcid.org/0000-0003-1104-4415КореннаяВ. В.KorennayaV. V.

Коренная Вера Вячеславовна - кандидат медицинских наук, доцент кафедры акушерства и гинекологии.

125993, Москва, ул. Баррикадная, д. 2/1, стр. 1

Vera V. Korennaya - MD, PhD, Associate Professor, Department of Obstetrics and Gynecology, Russian Medical Academy of Continuing Professional Education.

Building 1, 2/1, Barrikadnaya Street, Moscow, 125993

ФГБОУ ВО «Казанский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияKazan Medical UniversityRussian FederationФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Министерства здравоохранения Российской ФедерацииРоссияRussian Medical Academy of Continuous Professional EducationRussian Federation20232909202383107115Copyright © Фаткуллин И.Ф., Орлов Ю.В., Фаткуллина Л.С., Коренная В.В., 20232023Фаткуллин И.Ф., Орлов Ю.В., Фаткуллина Л.С., Коренная В.В.Fatkullin I.F., Orlov Y.V., Fatkullina L.S., Korennaya V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://fcm.kemsmu.ru/jour/article/view/763

Обзор посвящён современным возможностям и ближайшим перспективам решения проблем, связанных с ведением беременности у женщин с фиброидом матки, которые могут возникать уже на этапах прегравидарной подготовки пациентки и продолжаться в течение беременности и родов. Обсуждаются различные формы как естественного, так и оперативного родоразрешения, безопасность миомэктомии и её целесообразность до беременности, а также во время кесарева сечения, произведённого строго по показаниям. В контраверсиях подчёркивается необходимость проведения дальнейших исследований данной проблемы ввиду множества неоднозначных научных данных.

Here we review current opportunities in pregnancy management in women with uterine fibroids, also known as leiomyoma. Uterine fibroids are associated with a number of complications already at planning for pregnancy and also during pregnancy and labour. We discuss vaginal delivery and caesarian section in such patients, considering safety issue with regards to myomectomy and its expediency before pregnancy and during caesarean section. Multiple controversies and debates emphasize the need for the further research in this direction.

миома маткибеременность при миоме маткикесарево сечениемиомэктомияuterine myomapregnancycaesarean sectionmyomectomyReferencesChill H.H., Karavani G., Rachmani T., Dior U., Tadmor O., Shushan A. Growth pattern of uterine leiomyoma along pregnancy. BMC Women's Health. 2019;19(1):100. https://doi.org/10.1186/s12905-019-0803-5Chill H.H., Karavani G., Rachmani T., Dior U., Tadmor O., Shushan A. Growth pattern of uterine leiomyoma along pregnancy. BMC Women's Health. 2019;19(1):100. https://doi.org/10.1186/s12905-019-0803-5Фаткуллин И.Ф., Баканова А.Р., Илизарова Н.А., Галеев А.А. Новые возможности лечения миомы матки у женщин при нарушении репродуктивной функции. Доктор.Ру. 2016;8-9(125-126):32-37.Fatkullin IF, Bakanova AR, Ilizarova NA, Galeev AA. New possibilities of treatment of uterine fibroids in women with reproductive dysfunction. Doctor. Ru. 2016; 8-9(125-126):32-37. (In Russ).Pecout M., Cosson M., Collinet P., Rubod C., Giraudet G. Disappearance of a myoma after pregnancy in a 38 years old patient, treated by ulipristal acetate without success before getting pregnant. J. Gynecol. Obstet. Hum. Reprod. 2019;48(9):781-783. https://doi.org/10.1016/j.jogoh.2019.03.015Pecout M., Cosson M., Collinet P., Rubod C., Giraudet G. Disappearance of a myoma after pregnancy in a 38 years old patient, treated by ulipristal acetate without success before getting pregnant. J. Gynecol. Obstet. Hum. Reprod. 2019;48(9):781-783. https://doi.org/10.1016/j.jogoh.2019.03.015Baird D.D., Patchel S.A., Saldana T.M., Umbach D.M., Cooper T., Wegienka G., Harmon Q.E. Uterine fibroid incidence and growth in an ultra-sound-based, prospective study of young African Americans. Am. J. Obstet. Gynecol. 2020;223(3):402.e1-402.e18. https://doi.org/10.1016/j.ajog.2020.02.016Baird D.D., Patchel S.A., Saldana T.M., Umbach D.M., Cooper T., Wegienka G., Harmon Q.E. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans. Am. J. Obstet. Gynecol. 2020;223(3):402.e1-402.e18. https://doi.org/10.1016/j.ajog.2020.02.016Sohn G.S., Cho S., Kim Y.M., Cho C.H., Kim M.R., Lee S.R.; Working Group of Society of Uterine Leiomyoma. Current medical treatment of uterine fibroids. Obstet. Gynecol. Sci. 2018;61(2):192-201. https://doi.org/10.5468/ogs.2018.61.2.192Sohn G.S., Cho S., Kim Y.M., Cho C.H., Kim M.R., Lee S.R.; Working Group of Society of Uterine Leiomyoma. Current medical treatment of uterine fibroids. Obstet. Gynecol. Sci. 2018;61(2):192-201. https://doi.org/10.5468/ogs.2018.61.2.192Giuliani E., As-Sanie S., Marsh E.E. Epidemiology and management of uterine fibroids. Int. J. Gynaecol. Obstet. 2020;149(1):3-9. https://doi.org/10.1002/ijgo.13102Giuliani E., As-Sanie S., Marsh E.E. Epidemiology and management of uterine fibroids. Int. J. Gynaecol. Obstet. 2020;149(1):3-9. https://doi.org/10.1002/ijgo.13102Коротких И.Н., Лаптева Т.Н., Кураносова И.Ю. Анализ факторов риска, влияющих на осложненное течение беременности и исходы родов у женщин с миомой матки. Системный анализ и управление в биомедицинских системах. 2019;18(1):40-44. https://doi.org/10.25987/VSTU.2019.18.1.006Korotkih IN, Lapteva TN, Kuranosova IYu. Analysis of risk factors affecting the complicated course of pregnancy and birth outcomes in women with uterine myoma. System analysis and management in biomedical systems. 2019;18(1):40-44. (In Russ). https://doi.org/10.25987/VSTU.2019.18.1.006Krimou Y., Erraghay S., Guennoun A., Mamouni N., Bouchikhi C., Banani A. Myoma praevia and pregnancy. Pan. Afr. Med. J. 2019;33:216. https://doi.org/10.11604/pamj.2019.33.216.14898Krimou Y., Erraghay S., Guennoun A., Mamouni N., Bouchikhi C., Banani A. Myoma praevia and pregnancy. Pan. Afr. Med. J. 2019;33:216. https://doi.org/10.11604/pamj.2019.33.216.1489Abdullah R.K., Massey I.Y., Liu N., Zhao Y., Zeng H. The differences in characteristics of uterine leiomyomas and the diverse adverse pregnancy outcomes. J. Obstet. Gynaecol. 2021;41(6):841-847. https://doi.org/10.1080/01443615.2020.1846020Abdullah R.K., Massey I.Y., Liu N., Zhao Y., Zeng H. The differences in characteristics of uterine leiomyomas and the diverse adverse pregnancy outcomes. J. Obstet. Gynaecol. 2021;41(6):841-847. https://doi.org/10.1080/01443615.2020.1846020Vitagliano A., Noventa M., Di Spiezio Sardo A., Saccone G., Gizzo S., Borgato S., Vitale S.G., Lagana A.S., Nardelli G.B., Litta P.S., Saccardi C. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature. Arch. Gynecol. Obstet. 2018;297(4):823-835. https://doi.org/10.1007/s00404-017-4621-4Vitagliano A., Noventa M., Di Spiezio Sardo A., Saccone G., Gizzo S., Borgato S., Vitale S.G., Lagana A.S., Nardelli G.B., Litta P.S., Saccardi C. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature. Arch. Gynecol. Obstet. 2018;297(4):823-835. https://doi.org/10.1007/s00404-017-4621-4Амангелды Л.Б., Рымжанова А.З., Койшыбаева Н.С. Миома матки и беременность. Евразийское Научное Объединение. 2021;(2-3):141-142.Amangeldy LB, Rymzhanova AZ, Kojshybaeva NS. Uterine myoma and pregnancy. Eurasian Scientific Association. 2021;(2-3):141-142. (In Russ).Кулаков В.И., Шмаков Г.С. Миомэктомия и беременность. М.: Медпрессинформ; 2001.Kulakov VI, Shmakov GS. Miomjektomija i beremennost'. Moscow : Med-pressinform; 2001. (In Russ.)Milazzo G.N., Catalano A., Badia V., Mallozzi M., Caserta D. Myoma and myomectomy: Poor evidence concern in pregnancy. J. Obstet. Gynaecol. Res. 2017;43:1789-1804. https://doi.org/10.1111/jog.13437.Milazzo G.N., Catalano A., Badia V., Mallozzi M., Caserta D. Myoma and myomectomy: Poor evidence concern in pregnancy. J. Obstet. Gynaecol. Res. 2017;43:1789-1804. https://doi.org/10.1111/jog.13437Parazzini F., Gerli S., Bianchi S., Chiaffarino F., Favilli A. The Global Library of Women's Medicine Clinical guidance and resourses. In: Pregnancy complaints and complications: clinical presentations. 2021. Vol. 6: 1756-2228.Parazzini F., Gerli S., Bianchi S., Chiaffarino F., Favilli A. The Global Library of Women's Medicine Clinical guidance and resourses. In: Pregnancy complaints and complications: clinical presentations. 2021. Vol. 6: 1756-2228.Cagan M., Tanacan А., Donmez H.G., Fadiloglu Е., Unal C., Beksac M.S. The Effect of Small Size Uterine Fibroids on Pregnancy Outcomes in High-risk Pregnancies. Rev. Bras. Ginecol. Obstet. 2020;42(9):535-539. https://doi.org/10.1055/s-0040-1713913Cagan M., Tanacan А., Donmez H.G., Fadiloglu Е., Unal C., Beksac M.S. The Effect of Small Size Uterine Fibroids on Pregnancy Outcomes in High-risk Pregnancies. Rev. Bras. Ginecol. Obstet. 2020;42(9):535-539. https://doi.org/10.1055/s-0040-1713913Borghese G., Raffone A., Raimondo D., Saccone G., Travaglino A., Esposti E.D., Mastronardi M., Salucci P., Zullo F., Seracchioli R. Adhesion barriers in laparoscopic myomectomy: Evidence from randomized clinical trials. Int. J. Gynaecol. Obstet. 2021;152(3):308-320. https://doi.org/10.1002/ijgo.13495Borghese G., Raffone A., Raimondo D., Saccone G., Travaglino A., Esposti E.D., Mastronardi M., Salucci P., Zullo F., Seracchioli R. Adhesion barriers in laparoscopic myomectomy: Evidence from randomized clinical trials. Int. J. Gynaecol. Obstet. 2021;152(3):308-320. https://doi.org/10.1002/ijgo.13495Lasmar R.B., Lasmar B.P., Moawad N.S. Hysteroscopic myomectomy. Medicina. 2022;58(11):1627. https://doi.org/10.3390/medicina58111627Lasmar R.B., Lasmar B.P., Moawad N.S. Hysteroscopic myomectomy. Medicina. 2022;58(11):1627. https://doi.org/10.3390/medicina58111627Доброхотова Ю.Э., Данелян С.Ж., Боровкова Е.И., Нагайцева Е.А., Сарахова Д.Х., Селимшаева Д.С., Боровская К. А. Специфика ведения беременности у пациенток с миомой матки. Клинический случай. Гинекология. 2021;23(5):448-453. https://doi.org/10.26442/20795696.2021.5.200777Dobrokhotova IuE, Danelian SZh, Borovkova EI, Nagaitseva EA, Sarakhova DKh, Selimshaeva DS, Borovskaia KA. Pregnancy management in patients with uterine fibroids. Case report. Gynecology. 2021;23(2):448-453. (In Russ). https://doi.org/10.26442/20795696.2021.5.200777Буянова С.Н., Юдина Н.В., Гукасян С.А., Ермолаева Е.Е. Показания к миомэктомии во время беременности и ее исходы. Акушерство и Гинекология. 2019;6:70-77. https://doi.org/10.18565/aig.2019.6.70-77Buyanova SN, Yudina NV, Gukasyan SA, Ermolaeva EE. Indications for myomectomy during pregnancy and outcomes. Obstetrics and Gynecology. 2019;6:70-77. (In Russ). https://doi.org/10.18565/aig.2019.6.70-77Баринов С.В., Чуловский Ю.И., Мозговой С.И., Шамина И.В., Ледовских И.О., Фрикель Е.А. Опыт ведения беременных во II триместре с миомой матки больших размеров. Российский вестник акушера-гинеколога. 2020;20(5):54-60. https://doi.org/10.17116/rosakush20202005154Barinov SV, Chulovskij YuI, Mozgovoj SI, Shamina IV, Ledovskih IO, Frikel' EA. Experience in the Management of Pregnant Women in the Second Trimester with Large Uterine Myoma. Russian Bulletin of Obstetrician-Gynecologist. 2020;20(5):54-60. (In Russ). https://doi.org/10.17116/rosakush20202005154Тимохина Е.В., Губанова Е.В., Силаева Т.М. Беременность с миомой матки и после миомэктомии: результаты когортного исследования. Архив акушерства и гинекологии. 2019;6(3):132-139. https://doi.org/10.18821/2313-8726-2019-6-3-132-139Timokhina EV, Gubanova EV, Silayeva TM. Pregnancy with uterine myoma and after myomectomy: results of the cohort study. Archives of Obstetrics and Gynecology. 2019;6(3):132-139. (In Russ). https://doi.org/10.18821/2313-8726-2019-6-3-132-139Кухарчик Ю.В., Гутикова Л.В., Колесникова Т.А. Течение беременности и родов у женщин с миомой матки. В кн.: Современные перинатальные медицинские технологии в решении проблем демографической безопасности: сб. науч. тр. Минск: РНМБ; 2017. Ссылка активна на 14.05.2023. http://rep.med.by/handle/data/189Kuharchik JuV, Gutikova LV, Kolesnikova TA. Techenie beremennosti i rodov u zhenshhin s miomoj matki. In: Sovremennye perinatal'nye medicinskie tehnologii v reshenii problem demograficheskoj bezopasnosti: sbornik nauchnyh trudov. Minsk: RNMB; 2017. (In Russ). Available at: http://rep.med.by/handle/data/189. Accessed May 14, 2023.Lethaby A., Duckitt K., Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane database of systematic reviews. Version published: 2019 Sep. 19:CD000400 https://doi.org/10.1002/14651858.CD000400.pub4Lethaby A., Duckitt K., Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane database of systematic reviews. Version published: 2019 Sep. 19:CD000400 https://doi.org/10.1002/14651858.CD000400.pub4Claeys J., Hellendoorn I., Hamerlynck T., Bosteels J., Weyers S. The risk of uterine rupture after myomectomy: a systematic review of the literature and meta-analysis. Gynecol Surg. 2014;11:197-206. https://doi.org/10.1007/s10397-014-0842-8Claeys J., Hellendoorn I., Hamerlynck T., Bosteels J., Weyers S. The risk of uterine rupture after myomectomy: a systematic review of the literature and meta-analysis. Gynecol Surg. 2014;11:197-206. https://doi.org/10.1007/s10397-014-0842-8Lee S.J., Ko H.S., Na S., Bae J.Y., Seong W.J. Kim J.W., Shin J., Cho H.J., Choi G.Y., Kim J., Cho G.J., Park I.Y. Nationwide population-based cohort study of adverse obstetric outcomes in pregnancies with myoma or following myomectomy: retrospective cohort study. BMC Pregnancy Childbirth. 2020;20(1):716. https://doi.org/10.1186/s12884-020-03406-9Lee S.J., Ko H.S., Na S., Bae J.Y., Seong W.J. Kim J.W., Shin J., Cho H.J., Choi G.Y., Kim J., Cho G.J., Park I.Y. Nationwide population-based cohort study of adverse obstetric outcomes in pregnancies with myoma or following myomectomy: retrospective cohort study. BMC Pregnancy Childbirth. 2020;20(1):716. https://doi.org/10.1186/s12884-020-03406-9Goyal M., Dawood A.S., Elbohoty S.B., Abbas A.M., Singh P., Melana N., Singh S. Cesarean myomectomy in the last ten years; A true shift from contraindication to indication: A systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021;256:145-157. https://doi.org/10.1016/j.ejogrb.2020.11.008Goyal M., Dawood A.S., Elbohoty S.B., Abbas A.M., Singh P., Melana N., Singh S. Cesarean myomectomy in the last ten years; A true shift from contraindication to indication: A systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021;256:145-157. https://doi.org/10.1016/j.ejogrb.2020.11.008Tirnovanu M.C., Lozneanu L., Tirnovanu Ş.D., Tirnovanu V.G., Onofriescu M., Ungureanu C., Toma B.F., Cojocaru E. Uterine Fibroids and Pregnancy: A Review of the Challenges from a Romanian Tertiary Level Institution. Healthcare (Basel). 2022;10(5):855. https://doi.org/10.3390/healthcare10050855Tirnovanu M.C., Lozneanu L., Tirnovanu Ş.D., Tirnovanu V.G., Onofriescu M., Ungureanu C., Toma B.F., Cojocaru E. Uterine Fibroids and Pregnancy: A Review of the Challenges from a Romanian Tertiary Level Institution. Healthcare (Basel). 2022;10(5):855. https://doi.org/10.3390/healthcare10050855Huang Y., Ming X., Li Z. Feasibility and safety of performing cesarean myomectomy: a systematic review and meta-analysis. J. Matern. Fetal Neonatal. Med. 2022;35(13):2619-2627. https://doi.org/10.1080/14767058.2020.1791816Huang Y., Ming X., Li Z. Feasibility and safety of performing cesarean myomectomy: a systematic review and meta-analysis. J. Matern. Fetal Neonatal. Med. 2022;35(13):2619-2627. https://doi.org/10.1080/14767058.2020.1791816Kim M.J., Lee K., Park J.Y., Jo J.H., Park I.Y. The trend in cesarean myomectomies and the risk of obstetrical complications in Korea. BMC Pregnancy Childbirth. 2022;22(1):387. https://doi.org/10.1186/s12884-022-04674-3Kim M.J., Lee K., Park J.Y., Jo J.H., Park I.Y. The trend in cesarean myomectomies and the risk of obstetrical complications in Korea. BMC Pregnancy Childbirth. 2022;22(1):387. https://doi.org/10.1186/s12884-022-04674-3Jaiswar S.P., Srivastava P., Priyadarshini A., Deo S., Shankhwar P. Safety of cesarean myomectomy with huge myoma compared with uncomplicated cesarean section in Indian scenario. Int. J. Reprod. Contracept Obstet. Gynecol. 2015;4(6):1696-1699. https://doi.org/10.18203/2320-1770.ijrcog20151127Jaiswar S.P., Srivastava P., Priyadarshini A., Deo S., Shankhwar P. Safety of cesarean myomectomy with huge myoma compared with uncomplicated cesarean section in Indian scenario. Int. J. Reprod. Contracept Obstet. Gynecol. 2015;4(6):1696-1699. https://doi.org/10.18203/2320-1770.ijrcog20151127Li H., Du J., Jin L., Shi Z., Liu M. Myomectomy during cesarean section. Acta Obstet. Gyneco.l Scand. 2009;88(2):183-186. https://doi.org/10.1080/00016340802635526Li H., Du J., Jin L., Shi Z., Liu M. Myomectomy during cesarean section. Acta Obstet. Gyneco.l Scand. 2009;88(2):183-186. https://doi.org/10.1080/00016340802635526Sei K., Masui K., Sasa I., Furuya K. Size of uterine leiomyoma is a predictor for massive haemorrhage during caesarean delivery. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018;223:60-63. https://doi.org/10.1016/j.fertnstert.2010.03.035Sei K., Masui K., Sasa I., Furuya K. Size of uterine leiomyoma is a predictor for massive haemorrhage during caesarean delivery. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018;223:60-63. https://doi.org/10.1016/j.fertnstert.2010.03.035Carpini G.D., Morini S., Papiccio M., Serri M., Damiani V., Grelloni C., Clemente N., Ciavattini A. The association between childbirth, breastfeeding, and uterine fbroids: an observational study. Sci. Rep. 2019;9(1):10117. https://doi.org/10.1038/s41598-019-46513-0Carpini G.D., Morini S., Papiccio M., Serri M., Damiani V., Grelloni C., Clemente N., Ciavattini A. The association between childbirth, breastfeeding, and uterine fbroids: an observational study. Sci. Rep. 2019;9(1):10117. https://doi.org/10.1038/s41598-019-46513-0Orlando M., Kollikonda S., Hackett L., Kho R. Non-hysteroscopic Myomectomy and Fertility Outcomes: A Systematic Review. J. Minim. Invasive Gynecol. 2021; 28(3):598-618.e1. https://doi.org/10.1016/j.jmig.2020.10.006Orlando M., Kollikonda S., Hackett L., Kho R. Non-hysteroscopic Myomectomy and Fertility Outcomes: A Systematic Review. J. Minim. Invasive Gynecol. 2021; 28(3):598-618.e1. https://doi.org/10.1016/j.jmig.2020.10.006Радзинский В.Е., Ордиянц И.М., Хорольский В.А. Лечение миомы: вариативность как проблема. Сравнительная эффективность и безопасность двух схем мифепристона для медикаментозной терапии миомы матки. StatusPraesens. Гинекология, акушерство, бесплодный брак. 2015;3(26):39-45.Radzinskiy VE, Ordiyants IM, Khorol'skiy VA. Lechenie miomy: variativnost' kak problema. Sravnitel'naya effektivnost' i bezopasnost' dvukh skhem mifepristona dlya medikamentoznoy terapii miomy matki. StatusPraesens. Ginekologiya, akusherstvo, besplodnyy brak. 2015;3(26):39-45. (In Russ).Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017;108(3):416-425. https://doi.org/10.1016/j.fertnstert.2017.06.034Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017;108(3):416-425. https://doi.org/10.1016/j.fertnstert.2017.06.034Yang Q., Ciebiera M., Bariani M.V., Ali M., Elkafas H., Boyer T.G., Al-Hendy A. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr. Rev. 2022;43(4):678-719. https://doi.org/10.1210/endrev/bnab039Yang Q., Ciebiera M., Bariani M.V., Ali M., Elkafas H., Boyer T.G., Al-Hendy A. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr. Rev. 2022;43(4):678-719. https://doi.org/10.1210/endrev/bnab039Rezk A., Kahn J., Singh M. Fertility Sparing Management In Uterine Fibroids. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. PMID: 34662018Rezk A., Kahn J., Singh M. Fertility Sparing Management In Uterine Fibroids. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. PMID: 34662018Datir S.G., Bhake A. Management of Uterine Fibroids and Its Complications During Pregnancy: A Review of Literature. Cureus. 2022;14(11):e31080. https://doi.org/10.7759/cureus.31080Datir S.G., Bhake A. Management of Uterine Fibroids and Its Complications During Pregnancy: A Review of Literature. Cureus. 2022;14(11):e31080. https://doi.org/10.7759/cureus.31080Coutinho L.M., Assis W.A., Spagnuolo-Souza A., Reis F.M. Uterine Fibroids and Pregnancy: How Do They Affect Each Other? Reprod. Sci. 2022;29(8):2145-2151. https://doi.org/10.1007/s43032-021-00656-6Coutinho L.M., Assis W.A., Spagnuolo-Souza A., Reis F.M. Uterine Fibroids and Pregnancy: How Do They Affect Each Other? Reprod. Sci. 2022;29(8):2145-2151. https://doi.org/10.1007/s43032-021-00656-6

The authors declare that there are no conflicts of interest present.